Dopamine and the Gut Microbiota: Interactions Within the Microbiota–Gut–Brain Axis and Therapeutic Perspectives
International Journal of Molecular Sciences · 26.12.2025 · 27 (1) · 271
DOI: 10.3390/ijms27010271 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.12.2025. Verfasst von Aurelia Cristiana Barbu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania. Hauptthemen laut MEDLINE: Dopamine, Gastrointestinal Microbiome, Brain, Brain-Gut Axis. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The microbiota–gut–brain axis (MGBA) comprises a complex bidirectional communication network integrating neural, immune, metabolic, and endocrine pathways. Dopamine, traditionally viewed as a central neurotransmitter, also plays essential roles in the gastrointestinal (GI) tract, where it regulates motility, secretion, barrier homeostasis, and mucosal immunity. Growing evidence indicates that the gut microbiota significantly contributes to intestinal dopamine metabolism through specialized enzymatic pathways, particularly tyrosine decarboxylase in Enterococcus species and catechol dehydroxylase in Eggerthella species. These microbial reactions compete with host processes, alter dopaminergic tone, and degrade orally administered levodopa (L-DOPA), providing a mechanistic explanation for the variability in treatment response in Parkinson’s disease (PD). Beyond PD, microbially mediated alterations in dopaminergic signaling have been implicated in mood disorders, neurodevelopmental conditions, metabolic dysfunction, and immune-mediated diseases. This review synthesizes current mechanistic and translational evidence on the dopamine–microbiota interface, outlines microbial pathways shaping dopaminergic activity, and highlights therapeutic opportunities including microbiota modulation, dietary strategies, fecal microbiota transplantation, and targeted inhibitors of microbial dopamine metabolism. Understanding this interface offers a foundation for developing personalized approaches in neurogastroenterology and neuromodulatory therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
- Faculty of Medical Engineering, National University of Science and Technology Politehnica Bucharest, 060042 Bucharest, Romania.
ORCID-Profile: Aurelia Cristiana Barbu, Smaranda Stoleru, Elena Poenaru, Mihnea Costescu, Sorina Maria Aurelian
Zitieren
APA
Barbu, A. C., Stoleru, S., Zugravu, A., Poenaru, E., Dragomir, A., Costescu, M., Aurelian, S. M., Shhab, Y., Stoleru, C. M., Coman, O. A., & Fulga, I. (2025). Dopamine and the Gut Microbiota: Interactions Within the Microbiota–Gut–Brain Axis and Therapeutic Perspectives. International Journal of Molecular Sciences, 27(1), 271. https://doi.org/10.3390/ijms27010271
Vancouver
Barbu AC, Stoleru S, Zugravu A, Poenaru E, Dragomir A, Costescu M, et al. Dopamine and the Gut Microbiota: Interactions Within the Microbiota–Gut–Brain Axis and Therapeutic Perspectives. International Journal of Molecular Sciences. 2025;27(1):271. doi:10.3390/ijms27010271
BibTeX
@article{Barbu2025,
author = {Barbu, Aurelia Cristiana and Stoleru, Smaranda and Zugravu, Aurelian and Poenaru, Elena and Dragomir, Adrian and Costescu, Mihnea and Aurelian, Sorina Maria and Shhab, Yara and Stoleru, Clara Maria and Coman, Oana Andreia and Fulga, Ion},
title = {Dopamine and the Gut Microbiota: Interactions Within the Microbiota–Gut–Brain Axis and Therapeutic Perspectives},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {27},
number = {1},
pages = {271},
doi = {10.3390/ijms27010271}
}
EUVIMED